CFM
MBOT icon

Catalyst Funds Management’s Microbot Medical MBOT Stock Holding History

Catalyst Funds Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.8K Buy
+21,900
New +$48.9K 0.01% 539

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Catalyst Funds Management's MBOT Position: Q1 2026 in Review

Catalyst Funds Management opened a new position in Microbot Medical (MBOT) in Q1 2026: 21,900 shares worth $52.8K. The stake represents 0.01% of the portfolio and ranks #539 among its holdings.

79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Catalyst Funds Management held 21,900 shares of Microbot Medical worth $52.8K as of Q1 2026.
  • Microbot Medical was a new Catalyst Funds Management position in Q1 2026.
  • Microbot Medical made up 0.01% of Catalyst Funds Management's portfolio in Q1 2026, its #539 holding.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.